Intracoronary Delivery of Injectable Bioabsorbable Scaffold (IK-5001) to Treat Left Ventricular Remodeling After ST-Elevation Myocardial Infarction | Zendy

Norbert Frey | Zendy; Axel Linke | Zendy; Tim Süselbeck | Zendy; Jochen MüllerEhmsen | Zendy; Paul Vermeersch | Zendy; Danny Schoors | Zendy; Mark Rosenberg | Zendy; Florian Bea | Zendy; Shmuel Tuvia | Zendy; Jonathan Leor | Zendy

Open Access

Intracoronary Delivery of Injectable Bioabsorbable Scaffold (IK-5001) to Treat Left Ventricular Remodeling After ST-Elevation Myocardial Infarction

Author(s) -

Norbert Frey,

Axel Linke,

Tim Süselbeck,

Jochen MüllerEhmsen,

Paul Vermeersch,

Danny Schoors,

Mark Rosenberg,

Florian Bea,

Shmuel Tuvia,

Jonathan Leor

Publication year - 2014

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.114.001478

Subject(s) - medicine , myocardial infarction , cardiology , ejection fraction , ventricular remodeling , heart failure , tolerability , adverse effect , perfusion

We aimed to test, for the first time, the feasibility of intracoronary delivery of an innovative, injectable bioabsorbable scaffold (IK-5001), to prevent or reverse adverse left ventricular remodeling and dysfunction in patients after ST-segment-elevation myocardial infarction.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research